231 related articles for article (PubMed ID: 35404752)
1. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
Joo CW; Kim YK; Park SP
Ocul Immunol Inflamm; 2022 Jul; 30(5):1250-1254. PubMed ID: 35404752
[TBL] [Abstract][Full Text] [Related]
2. Vogt-Koyanagi-Harada disease following ChAdOx1 nCoV-19 and mRNA-1273 vaccination.
Rujkorakarn P; Patamatamkul S
J Fr Ophtalmol; 2023 Mar; 46(3):207-210. PubMed ID: 36775731
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
Koong LR; Chee WK; Toh ZH; Ng XL; Agrawal R; Ho SL
Ocul Immunol Inflamm; 2021 Aug; 29(6):1212-1215. PubMed ID: 34505819
[TBL] [Abstract][Full Text] [Related]
4. Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine.
De Domingo B; López M; Lopez-Valladares M; Ortegon-Aguilar E; Sopeña-Perez-Argüelles B; Gonzalez F
Cells; 2022 Mar; 11(6):. PubMed ID: 35326462
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease.
Xu K; Gao B; Li J; Xiang Y; Cao L; Zhao M
Hum Vaccin Immunother; 2023 Aug; 19(2):2220630. PubMed ID: 37282614
[TBL] [Abstract][Full Text] [Related]
6.
Brunet de Courssou JB; Tisseyre M; Hadjadj J; Chouchana L; Broca F; Terrier B; Duraffour P; Henriquez S
Ocul Immunol Inflamm; 2022 Jul; 30(5):1292-1295. PubMed ID: 35113742
[TBL] [Abstract][Full Text] [Related]
7. Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases.
de Queiroz Tavares Ferreira F; Araújo DC; de Albuquerque LM; Bianchini PM; Holanda EC; Pugliesi A
Ocul Immunol Inflamm; 2023 Aug; 31(6):1134-1140. PubMed ID: 35914285
[TBL] [Abstract][Full Text] [Related]
8. Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.
Sato T; Nihei R; Sora D; Nishio Y; Takeuchi M
Front Immunol; 2022; 13():967972. PubMed ID: 36248859
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of previously controlled Vogt-Koyanagi-Harada disease more than 46 years following COVID-19 vaccination: a case study.
Muto T; Sakamoto M; Imaizumi S; Kamoi K
J Int Med Res; 2024 Jan; 52(1):3000605231221081. PubMed ID: 38170955
[TBL] [Abstract][Full Text] [Related]
10. Mutton fat-like subretinal precipitates associated with Vogt-Koyanagi-Harada disease.
Hamabata K; Hashizume K; Ishikawa Y; Fujiwara T; Machida S; Kurosaka D
Ocul Immunol Inflamm; 2010 Jan; 18(1):44-5. PubMed ID: 20128649
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination.
Accorinti M; Saturno MC; Manni P
Ocul Immunol Inflamm; 2022 Jul; 30(5):1228-1233. PubMed ID: 35201950
[TBL] [Abstract][Full Text] [Related]
12. Bilateral Panuveitis Mimicking Vogt-Koyanagi-Harada Disease following the First Dose of ChAdOx1 nCoV-19 Vaccine.
Kim SY; Kang MS; Kwon HJ
Ocul Immunol Inflamm; 2022 Jul; 30(5):1218-1221. PubMed ID: 35113750
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report.
Niidome S; Usui Y; Tsubota K; Sugawara R; Goto H
Ocul Immunol Inflamm; 2023 Aug; 31(6):1305-1309. PubMed ID: 37084286
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
[TBL] [Abstract][Full Text] [Related]
15. Vogt-Koyanagi-Harada
Campos WR; Cenachi SPF; Soares MS; Gonçalves PF; Vasconcelos-Santos DV
Ocul Immunol Inflamm; 2021 Jan; 29(1):124-127. PubMed ID: 31603703
[No Abstract] [Full Text] [Related]
16. Bilateral retinal detachment in a patient with Vogt-Koyanagi-Harada syndrome.
McGehee BE; Chaljub G; Shah RK; Oto A; Camacho AC; Tang RA
Emerg Radiol; 2005 Nov; 11(6):366-71. PubMed ID: 16237574
[TBL] [Abstract][Full Text] [Related]
17. Vogt-Koyanagi-Harada Disease Associated with Hepatitis B Vaccination.
Sood AB; O'Keefe G; Bui D; Jain N
Ocul Immunol Inflamm; 2019; 27(4):524-527. PubMed ID: 29953303
[No Abstract] [Full Text] [Related]
18. Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome.
Golzarri MF; Cheja-Kalb R; Concha-Del-Río LE; Gonzalez-Salinas R; Arellanes-García L
Ocul Immunol Inflamm; 2022 Feb; 30(2):265-269. PubMed ID: 33021860
[TBL] [Abstract][Full Text] [Related]
19. A COVID-19 perspective of Vogt-Koyanagi-Harada disease.
Dutta Majumder P; Sadhu S; González-López JJ; Mochizuki M
Indian J Ophthalmol; 2023 Jun; 71(6):2587-2591. PubMed ID: 37322685
[TBL] [Abstract][Full Text] [Related]
20. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]